Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 44, Issue 21, Pages 3343-3346Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm0155401
Keywords
-
Categories
Ask authors/readers for more resources
Truncation of the original piperidino-2(S)-methyl piperazine lead structure 2, from a family of muscarinic antagonists, gave compound 8 which has improved selectivity for the HIV-1 co-receptor CCR5 over muscarinic receptors. Further optimization for pharmacokinetic properties afforded Sch-350634 (1), a prototypical piperazine-based CCR5 antagonist, which is a potent inhibitor of HIV-1 entry and replication in PBMCs. The title compound (1) has excellent oral bioavailability in rat, dog, and monkey.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available